LifeScience PLUS
Private Company
Funding information not available
Overview
LifeScience PLUS is a private, commercial-stage company specializing in advanced hemostasis and wound healing products. Its core technology is a patented, plant-based etherified carboxymethyl cellulose (eCMC) matrix that rapidly controls bleeding and creates an optimal environment for healing. The company is actively marketing its flagship BloodSTOP iX product across surgical, emergency, and chronic care settings, with clinical evidence supporting expansion into new applications like neurosurgery. LifeScience PLUS operates in the large and growing global advanced wound care market.
Technology Platform
Patented, plant-based etherified carboxymethyl cellulose (eCMC) matrix that activates the intrinsic coagulation cascade for rapid hemostasis and forms a protective, water-soluble membrane to promote healing.
Opportunities
Risk Factors
Competitive Landscape
Competes in the advanced hemostat and wound dressing market against giants like Johnson & Johnson (Ethicon), Baxter, and 3M, as well as specialized firms like Hemostasis, LLC. Differentiation is based on its plant-based, multi-action (hemostasis + healing) platform and water-soluble removal.